Garlic powder tablets reduce atherogenicity of low density lipoprotein. A placebo-controlled double-blind study

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 6, Issue 1, 1996, Pages 21-31

  Orekhov, A N ^a,b   Pivovarova, E M ^a   Tertov, V V ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

Antiatherosclerotic therapy; Atherosclerosis; Cell culture; Cholesterol; Garlic; Prevention; Proliferation

Indexed keywords

EID: 0002796393     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Orekhov AN, Tertov VV, Sobenin IA, Pivovarova EM (1995) Direct anti-atherosclerosis-related effects of garlic. Ann Med 27: 63-65
2. Orekhov AN, Tertov VV, Pokrovsky SN, Adamova IYu, Martsenyuk ON, Lyakishev AA, Smirnov VN (1988) Blood serum atherogenicity associated with coronary atherosclerosis. Evidence for nonlipid factor providing atherogenicity of low-density lipoproteins and an approach to its elimination. Circ Res 62: 421-429
3. Orekhov AN, Tertov VV, Kudryashov SA, Smirnov VN (1990) Triggerlike stimulation of cholesterol accumulation and DNA and extracellular matrix synthesis induced by atherogenic serum or low density lipoprotein in cultured cells. Circ Res 66: 311-320
4. Orekhov AN, Tertov VV, Mukhin DN, Mikhailenko IA (1989) Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells. Discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients. Biochem Biophys Res Commun 162: 206-211
5. Orekhov AN, Tertov VV, Mukhin DN (1991) Desialylated low density lipoprotein - naturally occuring modified lipoprotein with atherogenic potency. Atherosclerosis 86: 153-161
6. Orekhov AN, Tertov VV, Kudryashov SA, Khashimov KhA, Smirnov VN (1986) Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs. Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agents. Atherosclerosis 60: 101-110
7. Hara A, Radin NS (1978) Lipid extraction of tissue with low-toxicity solvent. Anal Biochem 90: 420-426
8. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275
9. Lindgren FT (1975) Preparative ultracentrifugal laboratory procedures and suggestions for lipoprotein analysis. In: Perkins EG (Ed), Analysis of lipids and lipoproteins. American Oil Chemical Society, New York, pp 205-224
10. Esterbauer H, Striegl G, Puhl H, Rothender M (1989) Continuous monitoring of in vitro oxidation of human low density lipoprotein Free Rad Res Commun 6: 67-75
11. Warren L (1959) The thiobarbituric acid assay of sialic acids. J Biol Chem 234: 1971-1975
12. Siegel G, Walter A, Schnalke F, Schmidt A, Buddecke E, Loirand G, Stock G (1991) Potassium channel activation, hyperpolarization, and vascular relaxation. Z Kardiol 80 (Suppl 7) 9-24
13. Gebhardt R (1991) Inhibition of cholesterol biosynthesis by a water-soluble garlic extract in primary cultures of rat hepatocytes. Arzneim-Forsch/Drug Res 41: 800-804
14. Dixon WJ, Brown MB (1977) Biomedical Computer Programs. P-Series. University of California Press, Berkeley, pp 185-198
15. Mansell P, Reckless JPD (1991) Garlic. Effects on serum lipids, blood pressure, coagulation, platelet aggregation, and vasodilatation. Br Med J 303: 379
16. Bordia A (1981) Effect of garlic on blood lipids in patients with coronary heart disease. Am J Clin Nutr 34: 2100-2103
17. Harenberg J, Giese C, Zimmermann R (1988) Effect of dried garlic on blood coagulation, fibrinolysis, platelet aggregation and serum cholesterol levels in patients with hyperlipoproteinemia. Atherosclerosis 74: 247-249
18. Kendler B (1987) Garlic (Allium sativum) and onion (Allium cepa): A review of their relationship to cardiovascular disease. Prev Med 16: 670
19. Mader FH (1991) Treatment of hyperlipidaemia with garlic-powder tablets. Evidence from the German Association of General Practioners' multicentric placebo-controlled double-blind study. Arzneim-Forsch/Drug Res 40: 3-8
20. Brosche T, Platt D (1991) Garlic. Br Med J 303: 785
21. Gebhardt R (1991) Inhibition of cholesterol biosynthesis by a water-soluble garlic extract in primary cultures of rat hepatocytes. Arzneim-Forsch/Drug Res 41: 800-804
22. Sendl A, Schliack M, Loser R, Stanislaus F, Wagner H (1992) Inhibition of cholesterol synthesis in vitro by extracts and isolated compounds prepared from garlic and wild garlic. Atherosclerosis 94: 79-85
23. Esterbauer H, Gebicki J, Puhl H, Juergens G (1992) The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radical Biol Med 13: 341-390
24. Tertov VV, Sobenin IA, Gabbasov ZA, Popov EG, Jaakkola O, Solakivi T, Nikkari T, Smirnov VN, Orekhov AN (1992) Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization. Lab Invest 67: 665-675
25. Phelps S, Harris WS (1993) Garlic supplementation and lipoprotein oxidation susceptibility. Lipids 28: 475-477
26. Orekhov AN, Tertov VV, Sobenin IA, Smirnov VN, Via DP, Guevara J Jr, Gotto AM Jr, Morrisett JD (1992) Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation. J Lipid Res 33: 805-817